{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:49:45Z","timestamp":1767703785037,"version":"3.37.3"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00259-019-04664-2","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T12:34:21Z","timestamp":1577968461000},"page":"2165-2174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preservation of brain metabolism in recently diagnosed Parkinson\u2019s impulse control disorders"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0008-2360","authenticated-orcid":false,"given":"Juan","family":"Mar\u00edn-Lahoz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederic","family":"Sampedro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Horta-Barba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u00fcl","family":"Mart\u00ednez-Horta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Aracil-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valle","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Bejr-kasem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berta","family":"Pascual-Sedano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"P\u00e9rez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Gironell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Pagonabarraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignasi","family":"Carri\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Kulisevsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"key":"4664_CR1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2016.12.058","volume":"374","author":"EM Maloney","year":"2017","unstructured":"Maloney EM, Djamshidian A, O\u2019Sullivan SS. Phenomenology and epidemiology of impulsive-compulsive behaviours in Parkinson\u2019s disease, atypical Parkinsonian disorders and non-Parkinsonian populations. J Neurol Sci. 2017;374:47\u201352.","journal-title":"J Neurol Sci"},{"key":"4664_CR2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s00115-003-1505-6","volume":"74","author":"C Berger","year":"2003","unstructured":"Berger C, Mehrhoff FW, Beier KM, Meinck H-M. Sexuelle Delinquenz und Morbus Parkinson [sexual delinquency and Parkinson\u2019s disease]. Nervenarzt. 2003;74:370\u20135.","journal-title":"Nervenarzt."},{"issue":"Suppl 1","key":"4664_CR3","first-page":"S43","volume":"48","author":"MJ Sobrido","year":"2009","unstructured":"Sobrido MJ, Dias-Silva JJ, Quint\u00e1ns B. Behavioral disorders in Parkinson\u2019s disease. Genetic, pharmacological and medico-legal aspects. Rev Neurol. 2009;48(Suppl 1):S43\u20138.","journal-title":"Rev Neurol"},{"key":"4664_CR4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","volume":"63","author":"D Weintraub","year":"2006","unstructured":"Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, et al. Dopamine agonist use is associated with impulse control disorders in Parkinson\u2019s disease. Arch Neurol. 2006;63:969\u201373.","journal-title":"Arch Neurol"},{"key":"4664_CR5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67:589\u201395.","journal-title":"Arch Neurol"},{"key":"4664_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/mds.25291","volume":"28","author":"J Bastiaens","year":"2013","unstructured":"Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ. Prospective cohort study of impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2013;28:327\u201333.","journal-title":"Mov Disord"},{"key":"4664_CR7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(18)30127-3","volume":"17","author":"J Marinus","year":"2018","unstructured":"Marinus J, Zhu K, Marras C, Aarsland D, van Hilten JJ. Risk factors for non-motor symptoms in Parkinson\u2019s disease. Lancet Neurol. 2018;17:559\u201368.","journal-title":"Lancet Neurol"},{"key":"4664_CR8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mds.21872","volume":"23","author":"IU Isaias","year":"2008","unstructured":"Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A. The relationship between impulsivity and impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2008;23:411\u20135.","journal-title":"Mov Disord"},{"key":"4664_CR9","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3389\/fpsyt.2018.00465","volume":"9","author":"J Mar\u00edn-Lahoz","year":"2018","unstructured":"Mar\u00edn-Lahoz J, Pagonabarraga J, Martinez-Horta S, Fernandez de Bobadilla R, Pascual-Sedano B, P\u00e9rez-P\u00e9rez J, et al. Parkinson\u2019s Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity. Front Psychiatry. 2018;9:465.","journal-title":"Front Psychiatry"},{"key":"4664_CR10","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/mds.25105","volume":"27","author":"A Djamshidian","year":"2012","unstructured":"Djamshidian A, O\u2019Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y, Foltynie T, et al. Decision-making, impulsivity and addictions: do Parkinson\u2019s disease patients jump to conclusions? Mov Disord. 2012;27:1137\u201345.","journal-title":"Mov Disord"},{"key":"4664_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.parkreldis.2011.09.007","volume":"18","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V. Impulse control disorders and depression in Finnish patients with Parkinson\u2019s disease. Parkinsonism Relat Disord. 2012;18:155\u201360.","journal-title":"Parkinsonism Relat Disord"},{"key":"4664_CR12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2013.09.006","volume":"20","author":"MB Callesen","year":"2014","unstructured":"Callesen MB, Weintraub D, Damholdt MF, M\u00f8ller A. Impulsive and compulsive behaviors among Danish patients with Parkinson\u2019s disease: prevalence, depression, and personality. Parkinsonism Relat Disord. 2014;20:22\u20136.","journal-title":"Parkinsonism Relat Disord"},{"key":"4664_CR13","doi-asserted-by":"crossref","unstructured":"Eisinger RS, Ramirez-Zamora A, Carbunaru S, Ptak B, Peng-Chen Z, Okun MS, et al. Medications, Deep Brain Stimulation, and Other Factors Influencing Impulse Control Disorders in Parkinson\u2019s Disease. Front Neurol [Internet]. 2019 [cited 2019 Mar 11];10. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2019.00086\/full.","DOI":"10.3389\/fneur.2019.00086"},{"key":"4664_CR14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/jnnp-2015-312848","volume":"87","author":"J Kraemmer","year":"2016","unstructured":"Kraemmer J, Smith K, Weintraub D, Guillemot V, Nalls MA, Cormier-Dequaire F, et al. Clinical-genetic model predicts incident impulse control disorders in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry. 2016;87:1106\u201311.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4664_CR15","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/j.parkreldis.2015.08.003","volume":"22","author":"I Aracil-Bola\u00f1os","year":"2016","unstructured":"Aracil-Bola\u00f1os I, Strafella AP. Molecular imaging and neural networks in impulse control disorders in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2016;22:S101\u20135.","journal-title":"Parkinsonism Relat Disord"},{"key":"4664_CR16","doi-asserted-by":"crossref","unstructured":"Martini A, Dal Lago D, Edelstyn NMJ, Salgarello M, Lugoboni F, Tamburin S. Dopaminergic neurotransmission in patients with Parkinson\u2019s disease and impulse control disorders: a systematic review and meta-analysis of PET and SPECT studies. Front Neurol [Internet]. 2018 [cited 2019 Mar 26];9. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2018.01018\/full.","DOI":"10.3389\/fneur.2018.01018"},{"key":"4664_CR17","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2011.08.001","volume":"310","author":"R Biundo","year":"2011","unstructured":"Biundo R, Formento-Dojot P, Facchini S, Vallelunga A, Ghezzo L, Foscolo L, et al. Brain volume changes in Parkinson\u2019s disease and their relationship with cognitive and behavioural abnormalities. J Neurol Sci. 2011;310:64\u20139.","journal-title":"J Neurol Sci"},{"key":"4664_CR18","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1007\/s00415-015-7892-3","volume":"262","author":"C Pellicano","year":"2015","unstructured":"Pellicano C, Niccolini F, Wu K, O\u2019Sullivan SS, Lawrence AD, Lees AJ, et al. Morphometric changes in the reward system of Parkinson\u2019s disease patients with impulse control disorders. J Neurol. 2015;262:2653\u201361.","journal-title":"J Neurol"},{"key":"4664_CR19","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/mds.26154","volume":"30","author":"R Biundo","year":"2015","unstructured":"Biundo R, Weis L, Facchini S, Formento-Dojot P, Vallelunga A, Pilleri M, et al. Patterns of cortical thickness associated with impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2015;30:688\u201395.","journal-title":"Mov Disord"},{"key":"4664_CR20","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/mp.2017.18","volume":"23","author":"F Imperiale","year":"2018","unstructured":"Imperiale F, Agosta F, Canu E, Markovic V, Inuggi A, Jecmenica-Lukic M, et al. Brain structural and functional signatures of impulsive\u2013compulsive behaviours in Parkinson\u2019s disease. Mol Psychiatry. 2018;23:459\u201366.","journal-title":"Mol Psychiatry"},{"key":"4664_CR21","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mds.27139","volume":"32","author":"A Tessitore","year":"2017","unstructured":"Tessitore A, De Micco R, Giordano A, di Nardo F, Caiazzo G, Siciliano M, et al. Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson\u2019s disease. Mov Disord. 2017;32:1710\u20139.","journal-title":"Mov Disord"},{"key":"4664_CR22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cortex.2017.06.008","volume":"94","author":"A Tessitore","year":"2017","unstructured":"Tessitore A, Santangelo G, De Micco R, Giordano A, Raimo S, Amboni M, et al. Resting-state brain networks in patients with Parkinson\u2019s disease and impulse control disorders. Cortex. 2017;94:63\u201372.","journal-title":"Cortex."},{"key":"4664_CR23","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1002\/hbm.24068","volume":"39","author":"A Verger","year":"2018","unstructured":"Verger A, Klesse E, Chawki MB, Witjas T, Azulay J-P, Eusebio A, et al. Brain PET substrate of impulse control disorders in Parkinson\u2019s disease: a metabolic connectivity study. Hum Brain Mapp. 2018;39:3178\u201386.","journal-title":"Hum Brain Mapp"},{"key":"4664_CR24","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00259-019-04396-3","volume":"46","author":"I Navalpotro-Gomez","year":"2019","unstructured":"Navalpotro-Gomez I, Dacosta-Aguayo R, Molinet-Dronda F, Martin-Bastida A, Botas-Pe\u00f1in A, Jimenez-Urbieta H, et al. Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson\u2019s disease patients with impulse control disorders. Eur J Nucl Med Mol Imaging. 2019;46:2065\u201376.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4664_CR25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease: reduced DaT BR predates ICD in PD. Mov Disord. 2014;29:904\u201311.","journal-title":"Mov Disord"},{"key":"4664_CR26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cpet.2013.10.006","volume":"9","author":"V Berti","year":"2014","unstructured":"Berti V, Mosconi L, Pupi A. Brain: normal variations and benign findings in FDG PET\/CT imaging. PET Clin. 2014;9:129\u201340.","journal-title":"PET Clin"},{"key":"4664_CR27","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1523\/JNEUROSCI.0582-08.2008","volume":"28","author":"S Hirano","year":"2008","unstructured":"Hirano S, Asanuma K, Ma Y, Tang C, Feigin A, Dhawan V, et al. Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson\u2019s disease. J Neurosci. 2008;28:4201\u20139.","journal-title":"J Neurosci"},{"key":"4664_CR28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1017\/S1461145710001203","volume":"14","author":"L Mah","year":"2011","unstructured":"Mah L, Zarate CA, Nugent AC, Singh JB, Manji HK, Drevets WC. Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression. Int J Neuropsychopharmacol. 2011;14:545\u201351.","journal-title":"Int J Neuropsychopharmacol"},{"key":"4664_CR29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00213-012-2953-0","volume":"227","author":"E Kim","year":"2013","unstructured":"Kim E, Howes OD, Turkheimer FE, Kim B-H, Jeong JM, Kim JW, et al. The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory : a dual [(11)C] raclopride and [(18)\u2009F] FDG imaging study with aripiprazole. Psychopharmacology. 2013;227:221\u20139.","journal-title":"Psychopharmacology"},{"key":"4664_CR30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/mds.26041","volume":"30","author":"JH Ko","year":"2015","unstructured":"Ko JH, Lerner RP, Eidelberg D. Effects of levodopa on regional cerebral metabolism and blood flow. Mov Disord. 2015;30:54\u201363.","journal-title":"Mov Disord"},{"key":"4664_CR31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/WCO.0000000000000494","volume":"30","author":"I Yakushev","year":"2017","unstructured":"Yakushev I, Drzezga A, Habeck C. Metabolic connectivity: methods and applications. Curr Opin Neurol. 2017;30:677\u201385.","journal-title":"Curr Opin Neurol"},{"key":"4664_CR32","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease: MDS-PD Clinical Diagnostic Criteria. Mov Disord. 2015;30:1591\u2013601.","journal-title":"Mov Disord"},{"key":"4664_CR33","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord. 2007;22:1689\u2013707 quiz 1837.","journal-title":"Mov Disord"},{"key":"4664_CR34","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov Disord. 2009;24:1461\u20137.","journal-title":"Mov Disord"},{"key":"4664_CR35","volume-title":"Gambling behavior and problem gambling","author":"RIF Brown","year":"1993","unstructured":"Brown RIF. Some contributions of the study of gambling to the study of other addictions. In: Eadington WR, Cornelius JA, editors. Gambling behavior and problem gambling. 1st ed. Reno: Univ of Nevada Pr; 1993.","edition":"1"},{"key":"4664_CR36","first-page":"191","volume":"10","author":"M Griffiths","year":"2005","unstructured":"Griffiths M. A \u2018components\u2019 model of addiction within a biopsychosocial framework. J Subst Abus. 2005;10:191\u20137.","journal-title":"J Subst Abus"},{"key":"4664_CR37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mds.24023","volume":"27","author":"D Weintraub","year":"2012","unstructured":"Weintraub D, Mamikonyan E, Papay K, Shea JA, Xie SX, Siderowf A. Questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease-rating scale. Mov Disord. 2012;27:242\u20137.","journal-title":"Mov Disord"},{"key":"4664_CR38","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129\u201370.","journal-title":"Mov Disord"},{"key":"4664_CR39","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord. 2010;25:2649\u201353.","journal-title":"Mov Disord"},{"key":"4664_CR40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"4664_CR41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00002826-200211000-00008","volume":"25","author":"J Marinus","year":"2002","unstructured":"Marinus J, Leentjens AF, Visser M, Stiggelbout AM, van Hilten JJ. Evaluation of the hospital anxiety and depression scale in patients with Parkinson\u2019s disease. Clin Neuropharmacol. 2002;25:318\u201324.","journal-title":"Clin Neuropharmacol"},{"key":"4664_CR42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","volume":"4","author":"SE Starkstein","year":"1992","unstructured":"Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, Robinson RG. Reliability, validity, and clinical correlates of apathy in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci. 1992;4:134\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"4664_CR43","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","volume":"51","author":"JH Patton","year":"1995","unstructured":"Patton JH, Stanford MS, Barratt ES. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51:768\u201374.","journal-title":"J Clin Psychol"},{"key":"4664_CR44","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/mds.22007","volume":"23","author":"J Pagonabarraga","year":"2008","unstructured":"Pagonabarraga J, Kulisevsky J, Llebaria G, Garc\u00eda-S\u00e1nchez C, Pascual-Sedano B, Gironell A. Parkinson\u2019s disease-cognitive rating scale: a new cognitive scale specific for Parkinson\u2019s disease. Mov Disord. 2008;23:998\u20131005.","journal-title":"Mov Disord"},{"key":"4664_CR45","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/mds.25568","volume":"28","author":"RF de Bobadilla","year":"2013","unstructured":"de Bobadilla RF, Pagonabarraga J, Mart\u00ednez-Horta S, Pascual-Sedano B, Campolongo A, Kulisevsky J. Parkinson\u2019s disease-cognitive rating scale: Psychometrics for mild cognitive impairment. Mov Disord. 2013;28:1376\u201383.","journal-title":"Mov Disord"},{"key":"4664_CR46","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00259-009-1264-0","volume":"36","author":"A Varrone","year":"2009","unstructured":"Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, N\u00e5gren K, et al. EANM procedure guidelines for PET brain imaging using [18F] FDG, version 2. Eur J Nucl Med Mol Imaging. 2009;36:2103\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4664_CR47","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Horta S, Moreu A, Perez-Perez J, Sampedro F, Horta-Barba A, Pagonabarraga J, et al. The impact of bilingualism on brain structure and function in Huntington\u2019s disease. Parkinsonism Relat Disord. 2019;60:92\u20137.","DOI":"10.1016\/j.parkreldis.2018.09.017"},{"key":"4664_CR48","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.clinthera.2007.09.021","volume":"29","author":"J Chen","year":"2007","unstructured":"Chen J, Swope D, Dashtipour K. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson\u2019s disease. Clin Ther. 2007;29:1825\u201349.","journal-title":"Clin Ther"},{"key":"4664_CR49","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A. 2000;97:11050\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4664_CR50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.neuroimage.2013.12.021","volume":"92","author":"DN Greve","year":"2014","unstructured":"Greve DN, Svarer C, Fisher PM, Feng L, Hansen AE, Baare W, et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage. 2014;92:225\u201336.","journal-title":"Neuroimage."},{"key":"4664_CR51","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.neuroimage.2016.02.042","volume":"132","author":"DN Greve","year":"2016","unstructured":"Greve DN, Salat DH, Bowen SL, Izquierdo-Garcia D, Schultz AP, Catana C, et al. Different partial volume correction methods lead to different conclusions: an (18)F-FDG-PET study of aging. Neuroimage. 2016;132:334\u201343.","journal-title":"Neuroimage."},{"key":"4664_CR52","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroimage.2014.01.060","volume":"92","author":"AM Winkler","year":"2014","unstructured":"Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. Neuroimage. 2014;92:381\u201397.","journal-title":"Neuroimage."},{"key":"4664_CR53","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/mds.23147","volume":"25","author":"H Rao","year":"2010","unstructured":"Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2010;25:1660\u20139.","journal-title":"Mov Disord"},{"key":"4664_CR54","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.biopsych.2012.01.006","volume":"71","author":"IM Balodis","year":"2012","unstructured":"Balodis IM, Kober H, Worhunsky PD, Stevens MC, Pearlson GD, Potenza MN. Diminished fronto-striatal activity during processing of monetary rewards and losses in pathological gambling. Biol Psychiatry. 2012;71:749\u201357.","journal-title":"Biol Psychiatry"},{"key":"4664_CR55","doi-asserted-by":"crossref","unstructured":"Sampedro F, Vilaplana E, de Leon MJ, Alcolea D, Pegueroles J, Montal V, et al. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls. Oncotarget [Internet]. 2015 [cited 2019 Nov 26];6. Available from: http:\/\/www.oncotarget.com\/fulltext\/5185.","DOI":"10.18632\/oncotarget.5185"},{"key":"4664_CR56","doi-asserted-by":"crossref","unstructured":"Riba J, Kr\u00e4mer UM, Heldmann M, Richter S, M\u00fcnte TF. Dopamine agonist increases risk taking but blunts reward-related brain activity. PLoS One [Internet]. 2008 [cited 2019 Mar 11];3. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2423613\/.","DOI":"10.1371\/journal.pone.0002479"},{"key":"4664_CR57","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/hbm.21067","volume":"32","author":"Z Ye","year":"2011","unstructured":"Ye Z, Hammer A, Camara E, M\u00fcnte TF. Pramipexole modulates the neural network of reward anticipation. Hum Brain Mapp. 2011;32:800\u201311.","journal-title":"Hum Brain Mapp"},{"key":"4664_CR58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000366485","volume":"70","author":"F Dragogna","year":"2014","unstructured":"Dragogna F, Mauri MC, Marotta G, Armao FT, Brambilla P, Altamura AC. Brain metabolism in substance-induced psychosis and schizophrenia: a preliminary PET study. Neuropsychobiology. 2014;70:195\u2013202.","journal-title":"Neuropsychobiology."},{"key":"4664_CR59","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/mds.26160","volume":"30","author":"C Siri","year":"2015","unstructured":"Siri C, Cilia R, Reali E, Pozzi B, Cereda E, Colombo A, et al. Long-term cognitive follow-up of Parkinson\u2019s disease patients with impulse control disorders. Mov Disord. 2015;30:696\u2013704.","journal-title":"Mov Disord"},{"key":"4664_CR60","doi-asserted-by":"crossref","unstructured":"Martini A, Dal Lago D, Edelstyn NMJ, Grange JA, Tamburin S. Impulse control disorder in Parkinson\u2019s disease: a meta-analysis of cognitive, affective, and motivational correlates. Front Neurol [Internet]. 2018 [cited 2019 Jun 4];9. Available from: https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2018.00654\/full#h10.","DOI":"10.3389\/fneur.2018.00654"},{"key":"4664_CR61","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1474-4422(18)30169-8","volume":"17","author":"KA Schindlbeck","year":"2018","unstructured":"Schindlbeck KA, Eidelberg D. Network imaging biomarkers: insights and clinical applications in Parkinson\u2019s disease. Lancet Neurol. 2018;17:629\u201340.","journal-title":"Lancet Neurol"},{"key":"4664_CR62","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.nbd.2012.03.029","volume":"46","author":"J Pagonabarraga","year":"2012","unstructured":"Pagonabarraga J, Kulisevsky J. Cognitive impairment and dementia in Parkinson\u2019s disease. Neurobiol Dis. 2012;46:590\u20136.","journal-title":"Neurobiol Dis"},{"key":"4664_CR63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2018.11.001","volume":"124","author":"F Sampedro","year":"2019","unstructured":"Sampedro F, Mar\u00edn-Lahoz J, Mart\u00ednez-Horta S, Pagonabarraga J, Kulisevsky J. Dopaminergic degeneration induces early posterior cortical thinning in Parkinson\u2019s disease. Neurobiol Dis. 2019;124:29\u201335.","journal-title":"Neurobiol Dis"},{"key":"4664_CR64","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp-2016-313918","volume":"88","author":"MJ Firbank","year":"2017","unstructured":"Firbank MJ, Yarnall AJ, Lawson RA, Duncan GW, Khoo TK, Petrides GS, et al. Cerebral glucose metabolism and cognition in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. J Neurol Neurosurg Psychiatry. 2017;88:310\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4664_CR65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1142\/S2575900018500015","volume":"01","author":"H Tan","year":"2018","unstructured":"Tan H, Li X, Wei K, Guan Y. Study on brain glucose metabolic networks in Parkinson\u2019s disease patients with visual spatial dysfunction by 18F-FDG PET imaging. Tradit Med Mod Med. 2018;01:27\u201331.","journal-title":"Tradit Med Mod Med"},{"key":"4664_CR66","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.nicl.2018.08.006","volume":"20","author":"DC Matthews","year":"2018","unstructured":"Matthews DC, Lerman H, Lukic A, Andrews RD, Mirelman A, Wernick MN, et al. FDG PET Parkinson\u2019s disease-related pattern as a biomarker for clinical trials in early stage disease. NeuroImage Clin. 2018;20:572\u20139.","journal-title":"NeuroImage Clin"},{"key":"4664_CR67","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s11682-016-9607-5","volume":"11","author":"S Martinez-Horta","year":"2017","unstructured":"Martinez-Horta S, Sampedro F, Pagonabarraga J, Fernandez-Bobadilla R, Marin-Lahoz J, Riba J, et al. Non-demented Parkinson\u2019s disease patients with apathy show decreased grey matter volume in key executive and reward-related nodes. Brain Imaging Behav. 2017;11:1334\u201342.","journal-title":"Brain Imaging Behav"},{"key":"4664_CR68","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/mds.22843","volume":"24","author":"K Dujardin","year":"2009","unstructured":"Dujardin K, Sockeel P, Delliaux M, Dest\u00e9e A, Defebvre L. Apathy may herald cognitive decline and dementia in Parkinson\u2019s disease. Mov Disord. 2009;24:2391\u20137.","journal-title":"Mov Disord"},{"key":"4664_CR69","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1523\/JNEUROSCI.0251-14.2014","volume":"34","author":"S Mart\u00ednez-Horta","year":"2014","unstructured":"Mart\u00ednez-Horta S, Riba J, de Bobadilla RF, Pagonabarraga J, Pascual-Sedano B, Antonijoan RM, et al. Apathy in Parkinson\u2019s disease: neurophysiological evidence of impaired incentive processing. J Neurosci. 2014;34:5918\u201326.","journal-title":"J Neurosci"},{"key":"4664_CR70","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.parkreldis.2011.10.005","volume":"18","author":"I Leroi","year":"2012","unstructured":"Leroi I, Andrews M, McDonald K, Harbishettar V, Elliott R, Byrne EJ, et al. Apathy and impulse control disorders in Parkinson\u2019s disease: a direct comparison. Parkinsonism Relat Disord. 2012;18:198\u2013203.","journal-title":"Parkinsonism Relat Disord"},{"key":"4664_CR71","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/gps.4161","volume":"30","author":"J Delrieu","year":"2015","unstructured":"Delrieu J, Desmidt T, Camus V, Sourdet S, Boutoleau-Bretonni\u00e8re C, Mullin E, et al. Apathy as a feature of prodromal Alzheimer\u2019s disease: an FDG-PET ADNI study. Int J Geriatr Psychiatry. 2015;30:470\u20137.","journal-title":"Int J Geriatr Psychiatry"},{"key":"4664_CR72","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jagp.2016.12.017","volume":"25","author":"JR Gatchel","year":"2017","unstructured":"Gatchel JR, Donovan NJ, Locascio JJ, Becker JA, Rentz DM, Sperling RA, et al. Regional 18F-Fluorodeoxyglucose hypometabolism is associated with higher apathy scores over time in early Alzheimer disease. Am J Geriatr Psychiatry. 2017;25:683\u201393.","journal-title":"Am J Geriatr Psychiatry"},{"key":"4664_CR73","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/mds.27395","volume":"33","author":"S Mart\u00ednez-Horta","year":"2018","unstructured":"Mart\u00ednez-Horta S, Perez-Perez J, Sampedro F, Pagonabarraga J, Horta-Barba A, Carceller-Sindreu M, et al. Structural and metabolic brain correlates of apathy in Huntington\u2019s disease. Mov Disord. 2018;33:1151\u20139.","journal-title":"Mov Disord"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04664-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-019-04664-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-019-04664-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:27:19Z","timestamp":1609460839000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-019-04664-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4664"],"URL":"https:\/\/doi.org\/10.1007\/s00259-019-04664-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"type":"print","value":"1619-7070"},{"type":"electronic","value":"1619-7089"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"24 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of informed consent"}}]}}